Celiac Disease Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Celiac Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Celiac Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Celiac Disease Drugs Overall Market Size
2.1 Global Celiac Disease Drugs Market Size: 2021 VS 2027
2.2 Global Celiac Disease Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Celiac Disease Drugs Players in Global Market
3.2 Top Global Celiac Disease Drugs Companies Ranked by Revenue
3.3 Global Celiac Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Celiac Disease Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Celiac Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Celiac Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Celiac Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Celiac Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Celiac Disease Drugs Market Size Markets, 2021 & 2027
4.1.2 First Line of Treatment
4.1.3 Second Line of Treatment
4.2 By Type - Global Celiac Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Celiac Disease Drugs Revenue, 2016-2021
4.2.2 By Type - Global Celiac Disease Drugs Revenue, 2022-2027
4.2.3 By Type - Global Celiac Disease Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Celiac Disease Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Celiac Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Celiac Disease Drugs Revenue, 2016-2021
5.2.2 By Application - Global Celiac Disease Drugs Revenue, 2022-2027
5.2.3 By Application - Global Celiac Disease Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Celiac Disease Drugs Market Size, 2021 & 2027
6.2 By Region - Global Celiac Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Celiac Disease Drugs Revenue, 2016-2021
6.2.2 By Region - Global Celiac Disease Drugs Revenue, 2022-2027
6.2.3 By Region - Global Celiac Disease Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Celiac Disease Drugs Revenue, 2016-2027
6.3.2 US Celiac Disease Drugs Market Size, 2016-2027
6.3.3 Canada Celiac Disease Drugs Market Size, 2016-2027
6.3.4 Mexico Celiac Disease Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Celiac Disease Drugs Revenue, 2016-2027
6.4.2 Germany Celiac Disease Drugs Market Size, 2016-2027
6.4.3 France Celiac Disease Drugs Market Size, 2016-2027
6.4.4 U.K. Celiac Disease Drugs Market Size, 2016-2027
6.4.5 Italy Celiac Disease Drugs Market Size, 2016-2027
6.4.6 Russia Celiac Disease Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Celiac Disease Drugs Market Size, 2016-2027
6.4.8 Benelux Celiac Disease Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Celiac Disease Drugs Revenue, 2016-2027
6.5.2 China Celiac Disease Drugs Market Size, 2016-2027
6.5.3 Japan Celiac Disease Drugs Market Size, 2016-2027
6.5.4 South Korea Celiac Disease Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Celiac Disease Drugs Market Size, 2016-2027
6.5.6 India Celiac Disease Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Celiac Disease Drugs Revenue, 2016-2027
6.6.2 Brazil Celiac Disease Drugs Market Size, 2016-2027
6.6.3 Argentina Celiac Disease Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Celiac Disease Drugs Revenue, 2016-2027
6.7.2 Turkey Celiac Disease Drugs Market Size, 2016-2027
6.7.3 Israel Celiac Disease Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Celiac Disease Drugs Market Size, 2016-2027
6.7.5 UAE Celiac Disease Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Celiac Disease Drugs Major Product Offerings
7.1.4 Roche Celiac Disease Drugs Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Celiac Disease Drugs Major Product Offerings
7.2.4 Merck Celiac Disease Drugs Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Celiac Disease Drugs Major Product Offerings
7.3.4 Johnson & Johnson Celiac Disease Drugs Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 BiolineRx
7.4.1 BiolineRx Corporate Summary
7.4.2 BiolineRx Business Overview
7.4.3 BiolineRx Celiac Disease Drugs Major Product Offerings
7.4.4 BiolineRx Celiac Disease Drugs Revenue in Global (2016-2021)
7.4.5 BiolineRx Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Celiac Disease Drugs Major Product Offerings
7.5.4 Pfizer Celiac Disease Drugs Revenue in Global (2016-2021)
7.5.5 Pfizer Key News
7.6 Innovate Biopharmaceuticals
7.6.1 Innovate Biopharmaceuticals Corporate Summary
7.6.2 Innovate Biopharmaceuticals Business Overview
7.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Major Product Offerings
7.6.4 Innovate Biopharmaceuticals Celiac Disease Drugs Revenue in Global (2016-2021)
7.6.5 Innovate Biopharmaceuticals Key News
7.7 ImmusanT
7.7.1 ImmusanT Corporate Summary
7.7.2 ImmusanT Business Overview
7.7.3 ImmusanT Celiac Disease Drugs Major Product Offerings
7.4.4 ImmusanT Celiac Disease Drugs Revenue in Global (2016-2021)
7.7.5 ImmusanT Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Celiac Disease Drugs Major Product Offerings
7.8.4 Novartis Celiac Disease Drugs Revenue in Global (2016-2021)
7.8.5 Novartis Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Celiac Disease Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Celiac Disease Drugs Revenue in Global (2016-2021)
7.9.5 Bristol-Myers Squibb Key News
7.10 Immunomedics
7.10.1 Immunomedics Corporate Summary
7.10.2 Immunomedics Business Overview
7.10.3 Immunomedics Celiac Disease Drugs Major Product Offerings
7.10.4 Immunomedics Celiac Disease Drugs Revenue in Global (2016-2021)
7.10.5 Immunomedics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Celiac Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Celiac Disease Drugs Market Drivers in Global Market
Table 3. Celiac Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Celiac Disease Drugs in Global Market
Table 5. Top Celiac Disease Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Celiac Disease Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Celiac Disease Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Celiac Disease Drugs Product Type
Table 9. List of Global Tier 1 Celiac Disease Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Celiac Disease Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Celiac Disease Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Celiac Disease Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Celiac Disease Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Celiac Disease Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Celiac Disease Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Celiac Disease Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Celiac Disease Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Celiac Disease Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Celiac Disease Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Celiac Disease Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Celiac Disease Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Celiac Disease Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Celiac Disease Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Celiac Disease Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Celiac Disease Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Celiac Disease Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Celiac Disease Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Celiac Disease Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Celiac Disease Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Celiac Disease Drugs Product Offerings
Table 32. Roche Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Celiac Disease Drugs Product Offerings
Table 35. Merck Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Celiac Disease Drugs Product Offerings
Table 38. Johnson & Johnson Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 39. BiolineRx Corporate Summary
Table 40. BiolineRx Celiac Disease Drugs Product Offerings
Table 41. BiolineRx Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Celiac Disease Drugs Product Offerings
Table 44. Pfizer Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Innovate Biopharmaceuticals Corporate Summary
Table 46. Innovate Biopharmaceuticals Celiac Disease Drugs Product Offerings
Table 47. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 48. ImmusanT Corporate Summary
Table 49. ImmusanT Celiac Disease Drugs Product Offerings
Table 50. ImmusanT Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Novartis Corporate Summary
Table 52. Novartis Celiac Disease Drugs Product Offerings
Table 53. Novartis Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Celiac Disease Drugs Product Offerings
Table 56. Bristol-Myers Squibb Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Immunomedics Corporate Summary
Table 58. Immunomedics Celiac Disease Drugs Product Offerings
Table 59. Immunomedics Celiac Disease Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Celiac Disease Drugs Segment by Type
Figure 2. Celiac Disease Drugs Segment by Application
Figure 3. Global Celiac Disease Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Celiac Disease Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Celiac Disease Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2020
Figure 8. By Type - Global Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 12. US Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 24. China Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Celiac Disease Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Celiac Disease Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Johnson & Johnson Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BiolineRx Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Pfizer Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. ImmusanT Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Novartis Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bristol-Myers Squibb Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Immunomedics Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics